WallStreetZenWallStreetZen

NASDAQ: LEXX
Lexaria Bioscience Corp Stock

$0.78+0.03 (+4%)
Updated May 26, 2023
LEXX Price
$0.78
Fair Value Price
$1.53
Market Cap
$4.69M
52 Week Low
$0.65
52 Week High
$3.60
P/E
-0.67x
P/B
0.94x
P/S
51.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$347.36k
Earnings
-$7.02M
Gross Margin
77.4%
Operating Margin
-2,022.11%
Profit Margin
-1,987.7%
Debt to Equity
0.05
Operating Cash Flow
-$5M
Beta
0.73
Next Earnings
Jul 12, 2023
Ex-Dividend
N/A
Next Dividend
N/A

LEXX Overview

Lexaria Bioscience Corporation is a biotech company developing a drug delivery technology, DehydraTECH, that improves the way active pharmaceutical ingredients enter the bloodstream. Dehydra being evaluated for orally administered anti-viral drugs and non-steroidal anti-inflammatory drugs. Lexaria Bioscience was incorporated in 2004 and is headquartered in Kelowna, British Columbia, Canada.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LEXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LEXX ($0.78) is undervalued by 48.78% relative to our estimate of its Fair Value price of $1.53 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
LEXX ($0.78) is significantly undervalued by 48.78% relative to our estimate of its Fair Value price of $1.53 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
LEXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more LEXX due diligence checks available for Premium users.

Be the first to know about important LEXX news, forecast changes, insider trades & much more!

LEXX News

Valuation

LEXX fair value

Fair Value of LEXX stock based on Discounted Cash Flow (DCF)
Price
$0.78
Fair Value
$1.53
Undervalued by
49.04%
LEXX ($0.78) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LEXX ($0.78) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
LEXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

LEXX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.67x
Industry
11.86x
Market
54.23x

LEXX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.94x
Industry
5.18x
LEXX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LEXX's financial health

Profit margin

Revenue
$35.0k
Net Income
-$1.3M
Profit Margin
-3,707.4%
LEXX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LEXX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.9M
Liabilities
$223.1k
Debt to equity
0.05
LEXX's short-term assets ($4.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LEXX's short-term assets ($4.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LEXX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
LEXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$32.7k
Financing
$11.2k
LEXX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LEXX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LEXX$4.69M+4.53%-0.67x0.94x
QLGN$4.70M+0.87%-0.21x0.97x
XBIO$4.76M-8.99%-0.77x0.37x
ARTL$4.83M+1.20%-0.46x0.27x
AMPE$4.53M+4.90%-0.31x0.58x

Lexaria Bioscience Stock FAQ

What is Lexaria Bioscience's quote symbol?

(NASDAQ: LEXX) Lexaria Bioscience trades on the NASDAQ under the ticker symbol LEXX. Lexaria Bioscience stock quotes can also be displayed as NASDAQ: LEXX.

If you're new to stock investing, here's how to buy Lexaria Bioscience stock.

What is the 52 week high and low for Lexaria Bioscience (NASDAQ: LEXX)?

(NASDAQ: LEXX) Lexaria Bioscience's 52-week high was $3.60, and its 52-week low was $0.65. It is currently -78.22% from its 52-week high and 20.62% from its 52-week low.

How much is Lexaria Bioscience stock worth today?

(NASDAQ: LEXX) Lexaria Bioscience currently has 5,985,650 outstanding shares. With Lexaria Bioscience stock trading at $0.78 per share, the total value of Lexaria Bioscience stock (market capitalization) is $4.69M.

Lexaria Bioscience stock was originally listed at a price of $98.19 in Feb 12, 2007. If you had invested in Lexaria Bioscience stock at $98.19, your return over the last 16 years would have been -99.2%, for an annualized return of -26.06% (not including any dividends or dividend reinvestments).

How much is Lexaria Bioscience's stock price per share?

(NASDAQ: LEXX) Lexaria Bioscience stock price per share is $0.78 today (as of May 26, 2023).

What is Lexaria Bioscience's Market Cap?

(NASDAQ: LEXX) Lexaria Bioscience's market cap is $4.69M, as of May 27, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lexaria Bioscience's market cap is calculated by multiplying LEXX's current stock price of $0.78 by LEXX's total outstanding shares of 5,985,650.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.